Greenrise Global Brands Inc (XCX) AI Stock Analysis

• Market Cap: C$258.28K
• Dividend Yield: N/A
• Average Volume (3M): 5.52K
• Price to Earnings (P/E): ―
• Beta (1Y): -3.55
• Revenue Growth: N/A
• EPS Growth: -406.12%
• Country: CA
• Employees: 200
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): >-0.01
• Shares Outstanding: 51,655,370
• 10 Day Avg. Volume: 2,200
• 30 Day Avg. Volume: 5,516
• PEG Ratio: 0.00
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: C$0.01 ▲(0.00% Upside)

The score is driven primarily by very weak financial performance (recurring losses, negative equity, and a thin asset base relative to debt) and pressured/volatile cash generation. Valuation is also unattractive to assess due to negative earnings and no dividend data, while technicals cannot be evaluated with the indicators provided.

Positive Factors

Strategic Partnerships

Strategic partnerships enhance distribution capabilities and market penetration, potentially driving long-term revenue growth and brand recognition.

Product Innovation

Commitment to innovation in product development can lead to competitive advantages and meet diverse consumer needs, supporting long-term business sustainability.

Market Expansion

Diversified sales channels allow for broader market reach and customer base expansion, which can stabilize revenue streams over time.

Negative Factors

High Leverage

High leverage and negative equity pose significant financial risks, limiting operational flexibility and increasing vulnerability to economic downturns.

Negative Cash Flow

Negative cash flow challenges the company's ability to fund operations and invest in growth, potentially hindering long-term viability.

Revenue Generation Challenges

Lack of revenue generation highlights operational inefficiencies and market challenges, threatening the company's ability to sustain its business model.

Greenrise Global Brands Inc Business Overview & Revenue Model

Company Description

Greenrise Global Brands Inc., through its subsidiaries, operates as a pharmaceutical supplier of medical cannabis products to pharmacies in Germany. It offers a range of CBD products consisting of tinctures, sprays, oils, and skincare products through drugstores; and imports and sells EU-GMP medical and cosmetic cannabis products. The company was formerly known as AMP Alternative Medical Products Inc. and changed its name to Greenrise Global Brands Inc. in November 2021. Greenrise Global Brands Inc. is based in Vancouver, Canada.

How the Company Makes Money

Greenrise Global Brands Inc generates revenue primarily through the sale of its cannabis and hemp-based products. These products are sold through various channels, including direct-to-consumer sales, retail partnerships, and online platforms. The company may also engage in wholesale distribution to other businesses and maintain strategic partnerships with retailers and distributors to expand its market reach. Additional revenue streams can include licensing agreements for their proprietary strains or technologies. Collaboration with research institutions for product development can also contribute to its earnings, along with any ancillary services related to the cannabis industry.

Greenrise Global Brands Inc Financial Statement Overview

Summary

The company is facing severe financial difficulties with no revenue generation and significant losses. It is highly leveraged with negative equity, indicating potential insolvency risks. Cash flow issues are prominent, with consistently negative free cash flow.

Income Statement

The company has shown no revenue in the TTM period and previous years, indicating severe challenges in generating sales. The net income remains negative, and the EBIT and EBITDA are also negative, reflecting operational inefficiencies and substantial losses.

Balance Sheet

The balance sheet reflects a highly leveraged position with a negative stockholders' equity, indicating insolvency risk. The debt-to-equity ratio is extremely high, suggesting financial instability. Additionally, the company has negative equity, which is a significant red flag.

Cash Flow

The company consistently generates negative free cash flow, which has deteriorated further in the TTM period. The operating cash flow is negative, and the free cash flow to net income ratio is undefined due to negative earnings, indicating liquidity issues and poor cash generation.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	0.00	0.00	0.00	0.00	452.87K	105.20K
Gross Profit	0.00	0.00	0.00	0.00	43.32K	-153.00
EBITDA	-621.10K	-411.10K	0.00	-744.80K	-2.60M	-2.06M
Net Income	-804.55K	-1.08M	―	-2.32M	-3.64M	-2.11M
Balance Sheet
Total Assets	17.33K	93.53K	441.82K	1.25M	252.94K	371.56K
Cash, Cash Equivalents and Short-Term Investments	17.33K	13.53K	31.53K	-619.68K	27.45K	60.45K
Total Debt	4.34M	2.62M	2.80M	3.15M	1.90M	1.08M
Total Liabilities	4.59M	2.79M	3.06M	3.56M	2.26M	1.34M
Stockholders Equity	-4.57M	-2.70M	-2.61M	-2.32M	-2.00M	-972.61K
Cash Flow
Free Cash Flow	-158.52K	-176.13K	199.35K	-1.08M	-1.95M	-1.88M
Operating Cash Flow	-158.52K	-176.13K	199.35K	-1.08M	-1.89M	-1.83M
Investing Cash Flow	149.13K	60.40K	387.50K	-531.00K	-63.15K	45.43K
Financing Cash Flow	15.12K	97.73K	-534.73K	1.51M	1.92M	1.63M

Greenrise Global Brands Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
XBRA	49 Neutral	C$420.72K	-0.31	―	―	―	―
XCX	41 Neutral	C$258.28K	-0.40	5.70%	―	―	-406.12%
CNTR	39 Underperform	C$289.94K	-1.05	―	―	―	―
LOWL	34 Underperform	C$272.55K	-0.01	―	―	―	―